Cleared Traditional

Blood Collection Needles (K200932) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K200932 · Vacutest Kima Srl · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2021
Decision
616d
Days
Class 2
Risk

K200932 is an FDA 510(k) clearance for the Blood Collection Needles. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Vacutest Kima Srl (Arzegrande, IT). The FDA issued a Cleared decision on December 14, 2021 after a review of 616 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Vacutest Kima Srl devices

Submission Details

510(k) Number K200932 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 07, 2020
Decision Date December 14, 2021
Days to Decision 616 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
487d slower than avg
Panel avg: 129d · This submission: 616d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 199
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K200932.
Safety Pen Needle
K210864 · Sandstone Medical (Suzhou), Inc. · Feb 2022
DropSafe Safety Pen Needles
K211716 · Htl Strefa SA · Jan 2022
UltiCare Disposable Pen Needles
K213407 · Ultimed Incorporated · Dec 2021
BD Nano 2nd Gen Pen Needle
K213156 · Becton, Dickinson and Company · Dec 2021
BD Nano 2nd Gen Pen Needle
K212015 · Becton, Dickinson and Company · Nov 2021
Insulin Pen Needle (Ordinary Type), Insulin Pen Needle (Safety Type)
K202319 · Tianjin Huahong Technology Co., Ltd. · Nov 2021